PA-PPG
8.8.2016 14:12:52 CEST | Business Wire | Press release
PPG (NYSE:PPG) today announced the completion of a COLORFUL COMMUNITIES™ project in Soborg, Denmark, that helped to revitalize and add shelter and seating to the parkour area of the City’s Arena, an outdoor activity space adjacent to the Hoje Gladsaxe housing project. The Colorful Communities program provides PPG employees and products along with financial contributions to bring color and vitality to communities where our company operates around the world. The program increases PPG’s commitment to invest in communities by adding $10 million to support efforts made during a 10-year period.
The project brought together more than 30 volunteers who are employees at PPG’s nearby architectural coatings, automotive refinish, and protective and marine coatings operations in Soborg to spend two days revitalizing the parkour area. PPG provided more than $18,500 for the project, as well as about 150 liters of DYRUP® Façade Extra paint products in 10 colors.
Young residents who use the City's Arena (Byens Arena) – an outdoor area that encourages movement, activity and play, mostly for residents of the adjacent 2,500-unit Hoje Gladsaxe housing project – expressed a desire for development and beautification of the parkour area. There was a need to make the area more welcoming in the hope of inviting more use. Large concrete features were installed to provide shelter and accommodation for visitors, and artist Anders Benmouyal facilitated a workshop where PPG employees and Hoje Gladsaxe residents came together and decorated the new concrete features.
“From the beginning, we were sure that revitalizing an area of Hoje Gladsaxe was right for this project – the residents are so close to our site, they are actually our neighbors,” said Peter Soerensen, PPG general manager, architectural coatings, Denmark. “We hope this is the beginning of close cooperation on more community initiatives. Already we are planning an educational day at our PPG site for local school students.”
The Colorful Communities program is PPG’s signature initiative for community engagement efforts, with the aim to protect and beautify the neighborhoods where PPG operates around the world. Together with community partners and PPG employees who volunteer, the program supports projects that transform community assets using donated PPG products. In 2015, PPG completed 11 Colorful Communities projects, and it expects to complete about 30 more this year.
PPG and the PPG Foundation aim to bring color and brightness to PPG communities around the world. We donated more than $7.8 million in 2015 to hundreds of community organizations across 20 countries. By investing in educational opportunities, we help grow today’s skilled workforce and develop tomorrow’s innovators in industries related to coatings and specialty materials. Plus, we empower PPG employees to make an impact for causes that are important to them by supporting their volunteer efforts and charitable giving. Learn more at www.ppgcommunities.com and follow @PPG_Communities on Twitter.
PPG: WE PROTECT AND BEAUTIFY THE WORLD™
At PPG (NYSE:PPG), we work every day to develop and deliver the paints, coatings and materials that our customers have trusted for more than 130 years. Through dedication and creativity, we solve our customers’ biggest challenges, collaborating closely to find the right path forward. With headquarters in Pittsburgh, we operate and innovate in more than 70 countries and reported net sales of $15.3 billion in 2015. We serve customers in construction, consumer products, industrial and transportation markets and aftermarkets. To learn more, visit www.ppg.com .
We protect and beautify the world and Colorful Communities are trademarks and the PPG Logo is a registered trademark of PPG Industries Ohio, Inc.
Dyrup is a registered trademark of Dyrup A/S.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160808005028/en/
Contact:
PPG Media:
Mark Silvey, +1 412-434-3046
Corporate
Communications
silvey@ppg.com
www.ppgcommunities.com
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Yubico Appoints Poupak Modirassari Enbom as Chief Marketing Officer to Accelerate Global Momentum and Drive Market Leadership30.3.2026 15:00:00 CEST | Press release
Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and a leading provider of hardware authentication security keys, today announced the appointment of Poupak Enbom as Chief Marketing Officer (CMO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330278027/en/ Enbom joins Yubico at a pivotal moment as organizations worldwide accelerate the shift to phishing-resistant authentication and modern identity security in the age of AI. “We’re excited to welcome Poupak to Yubico,” said Jerrod Chong, acting chief executive officer, Yubico. “As the threat landscape evolves with AI-driven attacks and increasing automation, organizations are rethinking how they secure digital identities of both humans and AI agents at scale. She brings a unique combination of technical depth, global leadership, and customer-first mindset that will help us continue to expand our impact and support our customers and partners around
Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 14:00:00 CEST | Press release
Fuel manufactured at Springfields has generated enough energy to supply the UK’s electricity demand for 26 years, avoiding the emission of nearly 3 billion tonnes of CO2 The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 5
HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 14:00:00 CEST | Press release
HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
